RT @FordePatrick: ~13yrs of neoadjuvant adventure comes to positive conclusion (for now)! In @NEJM today & presented at #ASCO25 5 yr surviv….

RT @DoctorJSpicer: It seems we are in a bit of a data quagmire. I often get asked how to choose between neoadjuvant versus perioperative im….

RT @Cancer_Cell: Online Now: Tumor neutrophils rewired from birth

I want to particularly thank all of my friends and colleagues in the @MThoracics lab and of course my fantastic mentors @DoctorJSpicer, @JonathanCools and @ronirayes for supporting my application and believing in me as an aspiring clinician scientist! It's a dream come true!.

I am thrilled to announce that I will be starting medical school this fall @mcgillu in the @McGill_MDPhD! Thank you so much to all my friends, family and mentors who made this possible :)

RT @DoctorJSpicer: Why is CM816 so important? After @FordePatrick beautiful presentation of these revolutionary data, let’s dig into why th….

RT @MeghanDeMeo: Very happy to share this published work done under the supervision of @DoctorJSpicer and in collaboration with @jvburnier….

RT @FordePatrick: Immunotherapy before surgery improves lung cancer survival in global clinical trial led by Irish cancer specialist | Eure….

RT @LFerri123: Neoadjuvant Avelumab (PD-L1) + Docetaxel triplet in gastro esophageal adenocarcinoma- a highly effective regimen. It’s been….

RT @DoctorJSpicer: Are you a trainee or junior faculty interested in early-stage lung cancer with a project you’d like to present? All disc….

RT @ELIXRConference: We are excited to announce registration for #ELIXR25 is officially open! You don't want to miss it, secure your spot n….

RT @EdmontonOilers: CONNOR DID IT!!!!!!!! 🇨🇦.

RT @DoctorJSpicer: Curious to see how those periop vs neoadj debates go now that OS is positive for CM816! Excellent news for patients and….

RT @DoctorJSpicer: Check out this awesome new study by the spatial biologists @McGillGCI led by @LysDesharnais @sorin_mark and PI @loganawa….

RT @DrewMoghanaki: Look no further to learn which battlefront needs the most help. Hint: it isn’t prostate cancer.

RT @annalsthorsurg: #EditorsChoice This invited expert review from @MHShahzad5, Kneuertz, and coauthors provides a comprehensive overview o….

RT @StephenVLiu: #ESMO24 @DoctorJSpicer with an update from CheckMate 77T (perioperative nivolumab vs placebo in resectable NSCLC). Impress….

RT @DoctorJSpicer: The optionality of adj chemo in the adj IO world of resected NSCLC seems to be the death knell for these trials. Only on….

RT @DoctorJSpicer: KN671 OS and HRQoL! Check it out:.

RT @DoctorJSpicer: Come join @loganawalsh and @IsaOpitz imagine the future of what precision surgery can offer patients when AI supports bi….